Drug Class
EGFR tyrosine kinase inhibitor
Type
ingredient
Active Ingredient
gefitinib
📋Overview
Gefitinib is a targeted cancer therapy known as an epidermal growth factor receptor (EGFR) inhibitor. It is primarily associated with the treatment of certain types of non-small cell lung cancer that have specific genetic mutations. By blocking the activity of EGFR, gefitinib can interfere with the growth and spread of cancer cells. This medication is often considered in cases where tumors show particular molecular characteristics.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Gefitinib
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.